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Abstract
Hypoglycemia is a common iatrogenic consequence of type 1 diabetes therapy
that can lead to central nervous system injury and even death if untreated. In
the absence of clinically effective neuroprotective drugs we sought to quantify
the putative neuroprotective effects of imposing hypothermia during the
reperfusion phase following aglycemic exposure to central white matter.
Mouse optic nerves (MONs), central white matter tracts, were superfused with
oxygenated artificial cerebrospinal fluid (aCSF) containing 10 mmol/L glucose
at 37°C. The supramaximal compound action potential (CAP) was evoked
and axon conduction was assessed as the CAP area. Extracellular lactate was
measured using an enzyme biosensor. Exposure to aglycemia, simulated by
omitting glucose from the aCSF, resulted in axon injury, quantified by electro-
physiological recordings, electron microscopic analysis confirming axon dam-
age, the extent of which was determined by the duration of aglycemia
exposure. Hypothermia attenuated injury. Exposing MONs to hypothermia
during reperfusion resulted in improved CAP recovery compared with control
recovery measured at 37°C, an effect attenuated in alkaline aCSF. Hypother-
mia decreases pH implying that the hypothermic neuroprotection derives
from interstitial acidification. These results have important clinical implica-
tions demonstrating that hypothermic intervention during reperfusion can
improve recovery in central white matter following aglycemia.
Introduction
It is widely accepted that hypothermia affords protection
during ischemia, that is, combined anoxia and hypo-
glycemia, in the central nervous system with the optimal
degree of protection occurring with hypothermia of 5 to
8°C (Wassink et al. 2018); hyperthermia augmenting injury
(Greer et al. 2008; Campos et al. 2013). Therapeutic
hypothermia has also successfully been used to spare neuro-
logical function following cardiac arrest (Hypothermia after
Cardiac Arrest Study, 2002; Bonaventura et al. 2016) and
as a result of severe hypoxic-ischemic encephalopathy
(Azzopardi et al. 2012), but had no beneficial effect on
patients subjected to severe traumatic brain injury (Cooper
et al. 2018), suggesting hypothermia’s benefits are only
manifest in injuries resulting from metabolic disruption.
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From the clinical perspective this is valuable information
since, given limited availability of neuroprotective thera-
pies, lowering patients’ temperature can be a therapeuti-
cally viable means of limiting brain damage following
stroke (Polderman 2004a,b).
The majority of available information regarding
hypothermic neuroprotection in the CNS concerns
ischemic injury to gray matter regions, notably the hip-
pocampus and the cortex (Greiner et al. 1998; Colbourne
et al. 1999). However, in the adult human white matter
constitutes 50% of the brain volume (Zhang and Sejnowski
2000), and all ischemic events involve not only gray matter
but the underlying white matter (Dirnagl et al. 1999).
Indeed lacunar infarcts are exclusively white matter injuries
(Fisher 1982). There is a paucity of information regarding
any putative neuroprotective effects of hypothermia on
aglycemic injury. Patients suffering from type 1 diabetes are
at risk of systemic hypoglycemia as a result of mismatching
insulin administration against prevailing blood glucose
levels (Frier et al. 2014). The brain is exquisitely sensitive
to shortfalls in delivery of glucose and responds with a
range of autonomic signals (Cryer 2015). The damage
incurred by aglycemia in the brain is region specific with
the dentate gyrus most sensitive based on electron micro-
scopic morphological analysis, and the cerebellum and
brainstem spared (Auer 2004). However, white matter is
also sensitive to hypoglycemia (Ma et al. 2009; Johkura
et al. 2012). There appear to be two phases of injury associ-
ated with hypoglycemia. The first phase occurs following
the loss of electrical excitability, which coincides with a flat
EEG (Auer et al. 1984). The ATP production decreases
leading to membrane depolarization and aspartate-
mediated activation of NMDA receptors (Yang et al. 2014),
opening of voltage gated Ca2+ channels and reversal of the
Na+-Ca2+ exchanger (Brown et al. 2001), all of which lead
to toxic Ca2+influx into axons. The second phase is associ-
ated with reperfusion of glucose, as occurs during medical
intervention, which offers an opportunity for therapeutic
intervention. In rat gray matter, the majority of the hypo-
glycemia induced injury is attributable to activation of
NADPH oxidase during reperfusion (Suh et al. 2007), sug-
gesting a potentially viable therapeutic strategy is to impose
hypothermia during reperfusion, whereas the mitochon-
drial permeability transition pore contributes to reperfu-
sion injury in cardiac myocytes (Morciano et al. 2017).
Prior data from rodent central white matter revealed there
is no advantage in imposing hypothermia following expo-
sure to anoxia (Stys et al. 1992a), but no equivalent infor-
mation is available for aglycemic injury.
In this study we used the established model of CNS white
matter injury, the mouse optic nerve (MON). We demon-
strated a linear relationship between the degree of injury
incurred by the MON and duration of exposure to aglycemia,
which served as a baseline against which to compare test data.
Imposing hypothermia during the entire experiment (aglyce-
mia exposure and reperfusion) improved recovery compared
with control experiments carried out at 37°C. Restricting
exposure of the MON to hypothermia exclusively to the
reperfusion phase resulted in equivalent CAP recovery to that
during combined aglycemia and reperfusion, similar to the
result reported in gray matter (Suh et al. 2007). The effect
appeared to be mediated via hypothermic acidification of the
aCSF suggesting that plausible strategies to protect the brain
from hypoglycemia-induced injury are to impose hypother-
mia during reperfusion of glucose or alter the patient’s blood
pH via intubated gases.
Materials and methods
Ethical approval
All experiments were approved by the University of Not-
tingham Animal Care and Ethics Committee, were carried
out in accordance with the Animals (Scientific Proce-
dures) Act 1986 under appropriate authority of establish-
ment, project and personal licenses, and conform to the
principles and regulations described in the Editorial by
Grundy (2015). Experiments were performed on male
CD-1 mice (weight 28–35 g, corresponding to 30–45 days
of age) purchased from Charles River Laboratories (Mar-
gate, Kent, CT9 4LT, UK). Mice were group housed with
ad libitum access to food and water, and maintained at
22–23°C on a 12:12 h light-dark cycle. Mice were killed
by Schedule 1 cervical dislocation; death was confirmed
by permanent cessation of the circulation. A total of 74
mice were used. In total 61 MON recordings were made.
The authors understand the ethical principles under
which The Journal of Physiology operates and declare this
work complies with this animal ethics checklist.
Adult male CD-1 mice were killed by Schedule 1 meth-
ods (see above). Optic nerves were dissected free, cut at the
optic chiasm and behind the orbit, gently freed from their
dural sheaths, placed in an interface perfusion chamber
(Model BSC-BU, Medical Systems Corp, Greenvale, NY,
USA), and maintained at 37°C with superfusion of control
artificial cerebrospinal fluid (aCSF) containing (in mM):
NaCl 126, KCl 3.0, CaCl2 2.0, MgCl2 2.0, NaH2PO4 1.2,
NaHCO3 26 and glucose 10. Bath pH was changed from
7.45 to 7.55 by increasing NaHCO3 to 35 mmol/L and
decreasing NaCl to 117 mM. A temperature change from
37°C to 27°C increases CO2 solubility and is calculated to
acidify aCSF from 7.40 to 7.29 (see below), confirmed by
experimental measurement. The perfusion chamber was
continuously aerated with a humidified gas mixture of 95%
O2/5% CO2. A feedback heating unit (Model TC 202A,
Harvard Apparatus, UK) maintained the temperature at
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the desired levels. The slow time course of the temperature
changes illustrated in Figure 4A highlights the inertia in
heating the chamber, thus to accelerate the transition of
temperature changes to within 5 min (see Fig. 6A) we
drained the reservoir of water via a sump in the base of the
unit and rapidly and repeatedly injected water at the
desired temperature into the reservoir until the stable,
desired temperature was reached.
Electrophysiology
Suction electrodes back-filled with the appropriate aCSF
were used for stimulation and recording. One electrode was
attached to the rostral end of the nerve for stimulation and
the second suction electrode was attached to the caudal end
of the nerve to record the compound action potential
(CAP), thus all recordings were orthodromic. A WPI Isos-
tim A320 constant current stimulator (WPI, Astonbury
Farm Business Centre, Stevenage, UK) was used to generate
a stimulus of 30 ls duration and its strength adjusted to
evoke the maximum CAP possible and then increased
another 25% (i.e. supramaximal stimulation, Stys et al.
1991). During an experiment, the supramaximal CAP was
elicited every 30 sec. The signal was amplified 1000x by a
Stanford Research Systems Preamplifier (SR560, Stanford
Research Systems, Inc., 1290-D Reamwood Ave., Sunny-
vale, CA 94089, USA), low pass filtered at 10 kHz and
acquired at 20 kHz (Digidata 1320A with Clampex 9.2,
Molecular Devices, Wokingham, UK). Optic nerve axon
function was monitored quantitatively as the area under
the supramaximal CAP. The area under the CAP represents
the best measure of the number of active axons because
currents generated by individual axons within a fiber tract
are considered to sum linearly (Cummins et al. 1979; Stys
et al. 1991). The curve fitting routine for detecting latency
to CAP failure has previously been described (Wender et al.
2000; Brown 2006).
Oxygen consumption
The O2 consumption was measured polarographically
using Clark oxygen electrodes (Rank Brothers, Bottisham,
UK) in a 1 mL sealed volume of aCSF, constantly stirred
and maintained at 37°C with a Haake Water circulator.
For each experiment, 2 MONs were placed in each cham-
ber and allowed to equilibrate for 30 min. For O2 mea-
surements the chamber was then sealed from the
atmosphere with a plunger (closed system). Care was
taken to expel all gas bubbles and the stirring speed
checked to ensure that the MONs were suspended. The
partial pressure of O2 (pO2) was measured at a polaro-
graphic voltage of 0.6 V with electrodes calibrated at
100% saturation in aCSF bubbled with 95% O2/5% CO2,
and at 0% by addition of Na2S2O4. aCSF was bubbled
with 95% O2/5% CO2 for 2 h at the test temperature to
ensure solution saturation with gas. The rate of O2 con-
sumption was measured as the change in pO2 over a per-
iod of time, which being linear, was the pO2 slope. The
pO2 was converted to molarities based on assumptions of
solubility of O2 at 35°C being 19.82 lmoles per mole
H2O, and 22.90 lmoles per mole H2O at 25°C (Lide
2006), and corrected for tissue weight.
Temperature dependence of CO2 solubility
The buffer system catalyzed by carbonic anhydrase:
CO2aq þH2O , H2CO3 , Hþ þHCO3
can be simplified since the concentration of H2CO3, carbonic
acid, is very low compared with the other components:
CO2 þH2O, Hþ þHCO3
where pH = log10 [H+]
From the Henderson-Hasselbalch relationship
pH ¼ pKalog ½acid½base
pKa for CO2/HCO3
 = 6.1 at 37°C at physiological ionic
strength (Chang 1981).
[Acid] ¼ [CO2aq
[CO2]aq = p(CO2) x K
T where p(CO2) is the partial
pressure of CO2 in the atmosphere and K
T is the solubil-
ity coefficient for CO2 at T˚C in mol atm
1 dm3
K298: solubility coefficient for CO2 at 25°C (298 K) =
0.034 mol atm1 dm3 (Haynes 2010).
KT¼K298exp
h
C
1
273þ T
 
 1
298
 i
where KT is the solubility coefficient for CO2 at T˚C and
C = 2400 for CO2.
If follows that K37 = 0.025 mol atm1 dm3, thus
[CO2]aq = 0.05 x K
37 at 5% CO2 at 37°C
[CO2]aq = 0.00125 M
[Base] = [HCO3
] in aCSF = 0.026 M
pH = 7.40 at 37°C, pH = 7.29 at 27°C and pH = 7.46 at
42°C
Transmission Electron Microscopy (TEM)
MONs were dissected as described above, laid out on
cardboard and then immediately fixed in 2% glutaralde-
hyde and 2% paraformaldehyde in 0.2 mol/L phosphate
buffer overnight and postfixed in 1% osmium tetroxide
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for 30 min. They were dehydrated in a graded ethanol
series and embedded in Transmit low viscosity resin
(TAAB). Semi thin sections were cut at 0.5 lm, stained
with toluidine blue and photographed using a Leica
DM400B light microscope with color digital camera and
Openlab darkroom software. Ultrathin sections (70–
90 nm) were prepared using a Reichert-Jung Ultracut E
ultramicrotome and mounted on 100 hexagonal copper
grids. They were contrasted using Uranyl acetate and Lead
Citrate and viewed using a JEOL 1010 TEM operated at
80 kV with digital image acquisition.
Computer simulation
The simulations were carried out using NEURON 7.4
(Hines and Carnevale 1997). The cell builder module was
used to construct a model of a myelinated axon consisting
of alternating myelinated internodal regions (INR) and
unmyelinated nodal compartments, with 26 of the former,
and 25 of the latter as previously described (Kolarik et al.
2013). The morphological dimensions, and passive mea-
sures of conductance, resistance, and capacitance were
based on data from corpus callosum axons and oligoden-
drocytes (Bakiri et al. 2011), and were integrated to con-
struct the basic axon model. The voltage dependent
conductances (Richardson et al. 2000), upon which action
potential conduction depends, were incorporated into the
nodal compartments. Simulated action potentials were
computed using backward Euler integration with a time
step of 0.01 msec. The temperature dependence of the rate
constants were based on previously published Q10 values
(Richardson et al. 2000). Action potentials were evoked by
a constant current pulse, and recorded 10 INRs distant
from the site of current injection.
Lactate Biosensors
Lactate biosensors (Frenguelli et al. 2003) were obtained
from Sarissa Biomedical Ltd (Coventry, UK). In practice,
the lactate signals were so large, relatively, that subtrac-
tion of the null signal had no effect on the signal ampli-
tude. The lactate biosensors (25 lm diameter and
500 lm length) were pressed against the optic nerve and
allowed to equilibrate for 30 to 60 min prior to experi-
ments. At the end of a recording the biosensors were cali-
brated using lactate concentrations of 10 lmol/L and
100 lmol/L.
Statistical analysis
Data are presented as the mean and the standard devia-
tion. The graphs showing CAP area versus time are aver-
aged traces of all observations recorded, with the recovery
determined as the ratio of the CAP area measured in the
last 5 min of the recovery period versus the baseline CAP
area. Statistical analysis was carried out using Pearson
correlation (Figs. 1B, 2B, 3B) and 2-way ANOVA
(Fig. 6C). Statistical significance was set at P < 0.05 and
all statistical analyses were performed using GraphPad
Prism 7.0 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Duration of exposure to aglycemia
determined CAP recovery
We have previously shown that exposure to aglycemia
caused delayed failure of the stimulus evoked CAP in
MONs with partial recovery of the CAP possible, but
dependent upon duration of aglycemia exposure (Baltan
Tekk€ok et al. 2003; Yang et al. 2014). In this study the
partial CAP recovery was further studied by exposing
MONs to aglycemia for a wider range of durations (from
20 min to 120 min). In MONs exposed to 20 min of
aglycemia the CAP started to fall but was fully rescued by
reperfusion with control aCSF. However, in MONs
exposed to 45 min of aglycemia the CAP fell to zero
where it remained for about 10 min before reperfusion
partially rescued the CAP, suggesting the injury process
commences after the CAP has completely failed, rather
than at the onset of CAP failure. Increasing the duration
of exposure to aglycemia resulted in correspondingly less
CAP recovery (Fig. 1A and B).
Electron micrographic analysis of axons was carried out
to determine if the loss of axon conduction correlated
with morphological detection of pathological changes as a
result of exposure to aglycemia. MONs under control
conditions (Fig. 1C) showed good preservation and dis-
played squamous or elliptical profiles, as well as the rela-
tively ordered morphology previously reported in control
rodent optic nerve axons (Garthwaite et al. 1999; Allen
et al. 2006). MONs exposed to 1 h aglycemia followed by
a 1 h reperfusion period in 10 mM glucose aCSF
displayed clear signs of axon swelling, intraaxonal com-
partmentalization, disrupted myelin and swollen mito-
chondria (Fig. 1D), effects that were more pronounced
after exposure to 2 h of aglycemia followed by reperfu-
sion (Fig. 1E).
Temperature affected aglycemia induced
injury
MONs were bathed in 10 mmol/L glucose for a baseline
period of up to 30 min, then exposed to aglycemia for
1 h, and allowed to recover in 10 mmol/L glucose aCSF
for 1 h at 27°C, 32°C, 34.5°C or 37°C for the duration of
2019 | Vol. 7 | Iss. 5 | e14007
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the experiment (Fig. 2A). In MONs maintained at 32°C,
34.5°C or 37°C the CAP fell at roughly the same time,
whereas at 27°C the failure was delayed (see Fig. 3A and
C). The degree of CAP recovery upon reperfusion of
aCSF containing 10 mM glucose was temperature depen-
dent, the MONs incubated at the lowest temperature
exhibiting the highest degree of recovery (Fig. 2B),
although if one compares the recovery of the CAP from
the end of the period of aglycaemia to the end of the
reperfusion period, the values at 27°C would be lower
due to the CAP not having fallen to zero by the end of
the period of aglycaemia.
The effects of aglycemia can be divided into phases as
shown in Figure 2C. The initial phase denotes the base-
line CAP against which the post-aglycemia CAP area can
be compared to determine the degree of injury incurred
by the MON. Introduction of aglycemia signifies the
onset of Phase 1. The CAP was initially fully maintained
as a result of glycogen metabolism but then fell to zero
once the glycogen was exhausted (Baltan Tekk€ok et al.
2003). Based on the data shown in Figure 1A and B we
presume that no injury is incurred by the tissue during
this phase. The failure of the CAP signaled the onset of
Phase 2. Phase 3 denotes the reperfusion of control aCSF
and (partial) recovery of the CAP. In the subsequent
experiments we sought to determine the effects of tem-
perature during phase 3.
Effect of temperature on aglycemia induced
CAP failure and lactate release
The effect of temperature on the latency to aglycemia-
induced CAP failure was assessed by measuring the
latency to 50% CAP area compared with its baseline
value. CAP failure occurred at similar times at 32°C to
37°C but was increased at 27°C (Fig. 3A and C). We have
previously shown that lactate measured at the pial-glial
boundary of the MON with enzyme electrodes offers a
convenient proxy for the supply of glycogen-derived lac-
tate within the tissue (Yang et al. 2014), a fall in lactate
levels indicative of exhaustion of glycogen stores. In the
presence of control aCSF lactate levels were steady at the
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Figure 1. CAP recovery is dependent upon duration of exposure to aglycemia. (A) CAP area versus time for MONs exposed to aglycemia for
20, 45, 60, 75, or 120 min, followed by a 60-minute recovery period in control aCSF. All experiments carried out at 37°C. The period from
20 to 0 min indicates the baseline prior to introduction of 0 glucose, and similar baseline periods are shown in Figure 2A and C, Figure 3A
and B and Figure 6A and B. (B) The CAP recovered to 98.5  2.9% (n = 5), 78.2  7.3% (n = 5), 45.0  13.9% (n = 5) 33.0  2.1%
(n = 4), or 7.3  6.4% (n = 5) after 20 min, 45 min, 60 min, 75 min, or 120 min of aglycemia, respectively, a linear relationship (Pearson
correlation: R2 = 0.94, P = 0.007). (C) Electron micrograph of a control MON cut in transverse section illustrates axons considered normal
based on their robust appearance. Scale bar = 2 lm also applies to D and E. (D) MONs exposed to 1 h of aglycemia followed by 1 h
reperfusion with control aCSF display swollen axons with appearance of intraaxonal compartmentalization, ruptured myelin, and swollen
mitochondria. (E) MONs exposed to 2 h of aglycemia display extreme injury including multiple swollen axons, loss of myelin wraps, appearance
of large intraaxonal vacuoles, and loss of axolemma.
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four temperatures employed (data not shown). Introduc-
tion of aglycemia led to a delayed fall in lactate, with
minimal effects at 32°C to 37°C, but a delayed fall in lac-
tate occurring at 27°C (Fig. 3B and C). The temperature
dependence of the latency to aglycemia-induced fall in
extracellular lactate was consistent with CAP failure
(Fig. 3C).
The delay in lactate failure, most apparent at 27°C and
illustrated in Figure 3B and C, suggested a decrease in
respiration and metabolic rate, which was supported by a
temperature dependent fall in oxygen uptake (Fig. 3D).
Effect of temperature on the CAP profile
In light of our use of the CAP profile as an index of axon
conduction, and the exposure of the MONs to varying
temperatures, it was necessary to quantify the effect of
temperature on the CAP profile by recording the CAP at
27°C then increasing the temperature in 5°C steps to
42°C. Figure 4A clearly shows an inverse relationship
between temperature and CAP area. It was also necessary
to determine whether switching to hypothermic tempera-
tures for an hour had any long lasting effects on the CAP
profile, which would confuse recovery data. Exposing the
MON to 27°C for 1 h temporarily increased the CAP area
but had no effect on the CAP profile (Fig. 4C). Represen-
tative CAPs recorded at four test temperatures are illus-
trated in Figure 4D, demonstrating that CAP area,
amplitude, and duration increase at lower temperatures.
It is technically difficult to record intracellular action
potentials in MON axons (Gordon et al. 1988) given their
small size (mean diameter 0.7 lm) (Allen et al. 2006),
thus we carried out computer simulations of intracellu-
larly recorded action potentials from small CNS white
matter axons (Kolarik et al. 2013), which show a similar
trend to those that contribute to the CAP, namely at
higher temperatures the action potential is of smaller
amplitude, shorter duration, and smaller area (Fig. 4B
and E).
Hypothermia induced restoration of the CAP
In a MON maintained at 37°C introduction of aglycemia
resulted in delayed failure of the CAP as previously
described. When the CAP area had fallen to about 10%
of baseline and the temperature was rapidly switched to
27°C, there was no immediate effect, with the CAP con-
tinuing to fall slowly toward zero. However, about
20 min after switching temperature the CAP area sud-
denly, and rapidly, increased toward baseline before
beginning a slow, inexorable decline toward zero. Upon
reperfusion of control aCSF the CAP partially recovered
(Fig. 5A and B). These data indicate that it is difficult to
exactly determine the point at which glycogen is depleted
that is, the onset of phase 3, suggesting it would be diffi-
cult to change the temperature during phase 3. Underesti-
mating the duration would lead to the situation
A
B
C
Figure 2. Ambient temperature determines CAP recovery after a
1 h period of aglycemia followed by 1 h reperfusion in control
aCSF. (A) MONs were exposed to 1 h of aglycemia followed by a
1 h recovery period in control aCSF at 27°C, 32°C, 34.5°C, or
37°C. (B) The CAP recovered to 44.8  5.0% (n = 7),
52.5  3.5% (n = 5), 62.3  8.9% (n = 8) or 87.9  3.7 (n = 6)
at 37°C, 34.5°C, 32°C or 27°C, respectively, a linear relationship
(Pearson correlation: R2 = 0.99, P = 0.006). (C) Schematic of the
multiple phases of aglycemia: baseline, (1) glycogen usage whose
exhaustion initiates CAP failure, (2) CAP failure in the continued
presence of aglycemia, and (3) reperfusion phase on reintroduction
of control aCSF. Inset illustrates CAPs from the baseline period (a)
and after exposure to aglycemia and recovery in 10 mM glucose
aCSF (b). Scale bars 0.5 msec and 1 mV.
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illustrated in Figure 5 and overestimating would poten-
tially lead to significant injury occurring after CAP failure
but prior to introduction of hypothermia. Thus equiva-
lent experiments of the type designed to investigate the
effects of temperature during exposure to anoxia on RON
(Fig. 5, Stys et al. 1992a) could not be accurately under-
taken and we focused on altering temperature during the
reperfusion phase.
Delayed hypothermia offers
neuroprotection after aglycemia
We tested whether hypothermia following aglycemia
could afford neuroprotection by imposing either a 60
min or 75 min period of aglycemia at 37°C followed by
reperfusion of control aCSF. After reperfusion of control
aCSF at the test temperature, the temperature was
switched back to 37°C to allow comparison of the CAP
areas with the baseline value, which was measured at
37°C. The CAP recovery was temperature dependent
(Fig. 6A and C). Qualitatively similar results were found
after 60 min of aglycemia (Fig. 6B and C).
Alkaline aCSF attenuates protection
afforded by hypothermia
We have previously demonstrated that acidifying the
aCSF improved CAP recovery following 90 min of aglyce-
mia as expected from an NMDA receptor-mediated injury
(Yang et al. 2014). We sought to determine any pH
related effects imposed by hypothermia on the aCSF.
Decreasing the temperature from 37°C to 27°C would be
expected to acidify aCSF from pH 7.4 to 7.29 (Chang
1981; Haynes 2010) offering a potential explanation of
the neuro-protective effects of hypothermia. Alkalizing
the pH of the aCSF (see Methods) in order to nullify the
0.1 pH unit acidification produced by hypothermia
resulted in an attenuation of CAP recovery (Fig. 7A–C).
A B
C D
Figure 3. Temperature dependence of aglycemia induced CAP failure and lactate release. (A) Aglycemia induced CAP failure that was
temperature dependent. The CAP was maintained for 26.5  6.2 min (n = 7), 26.0  6.8 min (n = 8), 26.7  4.2 min (n = 5), or
39.5  7.9 min (n = 6) at 37°C, 34.5°C, 32°C or 27°C, respectively. (B) Lactate release from MONs decreased on exposure to aglycemia in a
temperature dependent manner: lactate fell to 50% of baseline values after 19.6  2.2 min (n = 3), 20.1  1.2 min (n = 4), 21.5  3.3 min
(n = 3), or 28.6  5.8 min (n = 3) at 37°C, 34.5°C, 32°C or 27°C, respectively. (C) Plots of latency to CAP failure and latency to lactate fall did
not show any discernable temperature dependence between 37°C and 32°C, but both parameters were increased at 27°C. (D) Oxygen uptake
(lmoles O2 g
1 min1) in MONs was 0.37  0.08 lmoles O2 g1 min1 (n = 2), 1.04  0.45 lmoles O2 g1 min1 (n = 2), or
1.29  0.35 lmoles O2 g1 min1 (n = 2) at 27°C, 32°C or 37°C, respectively (Pearson correlation: R2 = 0.93, P = 0.04).
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Discussion
Mammals evolved to function optimally at a temperature
maintained by the organism independent of ambient con-
ditions; in the case of mammals this temperature is 37°C.
Such is the sensitivity of proteins to temperature that
even slight deviations from 37°C disrupts function, an
effect exhibited in the temperature dependent variations
in conduction of MON axons, a central white matter
tract, where hypothermia decreased conduction velocity
A B
C
E
D
Figure 4. Effect of temperature on CAP profile. (A) CAP area was temperature sensitive, hypothermia resulting in increased CAP area. The
open squares denote individual CAP areas (left y-axis), the contiguous line denotes temperature (right y-axis). CAP area was normalized to 1 at
37°C. (B) CAP area (□, n = 4) and area of modeled action potentials shown in D (M) plotted against temperature, normalized to 1 at 37°C,
showing an inverse relationship between temperature and CAP area, which is quantified to illustrate the negative correlation (n = 4,
P < 0.0001 two-tailed Spearman Rank correlation). (C) Switching temperature from 37°C to 27°C for 1 h reversible increased CAP area but
had no irreversible effect on the CAP profile. Insert shows CAPs recorded at the time points indicated with overlap between the CAP traces
recorded at 37°C. Single trace representative of 4 similar recordings. (D) Example CAPs recorded at indicated temperatures. Scale bars 1 msec
and 1 mV. (E) Example simulations of intracellular action potentials modeled at indicated temperatures. Scale bars 1 ms and 40 mV.
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but increased compound action potential area. The Q10
of most biological systems is between 2 and 3, thus
decreases in temperature of only a few degrees can signifi-
cantly attenuate the metabolic rate, decreasing oxygen
consumption and preserving energy substrates. This has
been used advantageously to reduce brain injury during
the inevitable disruption in delivery of energy substrates
to the brain during planned cardiac surgery. Imposing
hypothermia on patients suffering from stroke can also
reduce injury, thus a therapy that can be imposed after
the onset of a metabolic insult (stroke, hypoglycemia)
would be clinically beneficial given the unpredictable nat-
ure of neurological trauma.
CAP profile and temperature
The CAP profile recorded from the rat optic nerve is tem-
perature dependent with hypothermia promoting elon-
gated CAPs and increased CAP area (Stys et al. 1992a).
We demonstrated similar effects in the MON. These
results are likely due to the temperature dependence of
ion channel kinetics, where hypothermia is associated
with slower opening and closing of channels (Hille 2001).
We are unable to infer with any confidence whether the
greater effect of hypothermia on the repolarizing phase of
the action potential is indicative of a heightened sensitiv-
ity of K+ channels to temperature, but selective ion chan-
nel sensitivity to temperature has been reported (Sarria
et al. 2012). However, the axoplasmic conductance will
also increase with temperature resulting in increased con-
duction velocity (Moore et al. 1978). The rodent optic
nerve membrane potential has recently been shown as
temperature sensitive (Coates et al. 2015), but the small
temperature range employed in this study would have
minimal effects on conduction velocity.
Aglycemic injury to MON axons
We studied white matter aglycemic injury and found that
hypothermia was neuroprotective, suggesting a novel
therapy to treat patients suffering from iatrogenic hypo-
glycemia associated with insulin therapy. Although
A
B
b c d
e f g h
a
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
(h) 
(g) 
0 glucose 
Figure 5. Failing CAP can be restored by rapid exposure hypothermia. (A) On exposure to aglycemia at 37°C there is a delayed failure of the
CAP as seen in Figures 1A and 2A. However, upon rapid change of temperature from 37°C to 27°C the CAP, although almost completely lost,
suddenly, and rapidly increases temporarily toward baseline before slowly falling during continuous aglycemia at 27°C. Upon reperfusion of
control aCSF the CAP partially recovers. (B) Individual CAP profiles at the times indicated in A.
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hypothermia is used to treat patients, the rodent model
offers the advantage that we can control the injury pro-
cess and the onset of the hypothermia. The mammalian
nervous system has a high demand for energy substrate in
the form of blood borne glucose and oxygen (Clarke and
Sokoloff 1999). Numerous studies in the rodent optic
nerve have demonstrated the pathology associated with
depriving the tissue of oxygen (Stys et al. 1992b), glucose
(Brown et al. 2001) or a combination of the two (Fern
and Ransom 1997). Initial studies in rat demonstrated a
A
B
C
Figure 6. CAP recovery is temperature dependent during
reperfusion. (A) MONs were exposed to 75 min of aglycemia
(horizontal line from 0 to 75 mins) at 37°C followed by 1 hr of
reperfusion at 27°C (s), 32°C (M), 34.5°C (}) or 37°C (h). The right
axis denotes the temperature recordings (upper black lines). The
lower section of the upper horizontal bar denotes the period of
temperature change during reperfusion of control aCSF. At 135 min
the temperature was switched to 37°C. Following 75 mins of
aglycemia hypothermia increased CAP recovery from 33.0  1.2%
(n = 5) at 37°C to 37.5  7.5% (n = 6), 52.5  4.4% (n = 5), or
63.0  4.1% (n = 6) at 32°C, 34.5°C or 27°C, respectively. (B)
Similar to A except that the exposure to aglycemia at 37°C was for
60 min (horizontal line for 0 to 60 min). Qualitatively similar results
were found after 60 min of aglycemia with CAP recovery of
45.0  6.2% (n = 7), 51.8  6.3% (n = 6), 66.2  7.6% (n = 5),
or 76.4  5.2% (n = 6) at 37°C, 34.5°C, 32°C or 27°C, respectively.
(C) Plot of CAP recovery after 60 min (}) or 75 min (h) aglycemia
followed by reperfusion of control aCSF at temperatures from 27°C
to 37°C. The filled squares connected by the dotted line are the data
from Figure 2A illustrating CAP recovery when the temperature was
altered during the entire experiment. A 2-way ANOVA detected no
significant difference between any pairing of the data €y and }:
P = 0.75, but the overall effect of temperature was significant,
P = 0.001. However, there was a significant difference when
comparing h and }: P = 0.03, with the overall effect of temperature
significant, P < 0.0001.
A
B
C
Figure 7. Alkalization of aCSF attenuated hypothermia induced
CAP recovery. (A) MONs were exposed to aglycemia for an hour
followed by reperfusion for an hour in 10 mM glucose at 27°C. (B)
Similar to A with the exception that the aCSF during reperfusion
was at pH 7.55 (indicated by the dotted line). (C) Increasing the
aCSF pH to 7.55 to offset the hypothermic 0.1 pH unit acidification
resulted in an attenuation of CAP recovery, from 72.6  5.2% to
49.7  7.8% (P < 0.05, n = 6).
2019 | Vol. 7 | Iss. 5 | e14007
Page 10
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Hypothermic Neuroprotection of White Matter A. M. Brown et al.
rapid fall in the CAP area on exposure to anoxia followed
by irreversible injury (Stys et al. 1992b). Removal of glu-
cose led to a delayed failure of the CAP in MON, endoge-
nous glycogen present in astrocytes acting as an energy
buffer to sustain axon conduction in the short term upon
removal of glucose, but once the glycogen was depleted
conduction failed (Brown et al. 2001). The degree of
injury incurred by the MON exposed to aglycemia was
dependent upon the duration of exposure to aglycemia
(Yang et al. 2014) (Fig. 1). Although exposure to aglyce-
mia for 20 min caused the CAP to fail reperfusion with
10 mM glucose fully restored the CAP indicating that the
injury process is initiated after complete CAP failure
(phase 1 in Fig. 2C). The failure of the CAP coincides
with activation of NMDA receptors on oligodendrocytes
by aspartate released from astrocytes (Yang et al. 2014),
activation of voltage gated Ca2+ channels (VGCC) and
reversal of the Na+-Ca2+ exchanger (Brown et al. 2001).
Each of these pathways leads to toxic Ca2+ accumulation
in axons (VGCC and Na+-Ca2+ exchanger) and oligoden-
drocytes (NMDA receptors). It should also be noted that
the presence of NMDA receptors on oligodendrocytes has
been proposed as a mechanism for oligodendrocyte glu-
cose uptake and subsequent shuttling of lactate to axons
(Saab et al. 2016). Thus the injury process is activated
once the ATP levels fall and disequilibrium of trans-mem-
brane ion concentrations occurs. In gray matter a large
proportion of the injury is incurred during the reperfu-
sion of glucose and is caused by NADPH activation (Suh
et al. 2007).
Mechanism(s) of hypothermic
neuroprotection
The role of glycogen in the neuroprotective effects of
hypothermia adds a level of complexity that is lacking from
the anoxia studies. At the onset of aglycemia glycogen is
metabolized to lactate, which fuels axon conduction until
glycogen is exhausted. Lowering the temperature would
lead to a decreased metabolic rate thus extending the dura-
tion in which glycogen supports function. However, this
was only seen at the extreme of our range, 27°C. At temper-
atures of 32°C or 34.5°C there is no significant increase in
latency to CAP failure, reflected in the static latency of lac-
tate fall under identical conditions. These data suggest that
modest hypothermia has no significant effect on glycogen
metabolism, which is corroborated by the small decrease in
O2 uptake at 32°C. Thus with modest hypothermia any
neuro-protection afforded is not due to a decreased rate of
glycogen metabolism.
We have previously shown that at 37°C the CAP recov-
ers to about 49% following 1 h of aglycemia and 1 h of
reperfusion in 10 mmol/L glucose. Inhibitors of voltage
gated Ca2+ channels, Na+ Ca2+ exchanger or NMDA
receptors, improved CAP recovery by about 25% (Brown
et al. 2001), 34% (Brown et al. 2001) or 15% (Yang et al.
2014), respectively, indicating there are multiple mecha-
nisms involved in the injury process, although ultimately
they all involve intracellular influx of Ca2+ (CAP recovers
to 100% if Ca2+ is excluded from the aCSF) (Brown et al.
2001). Multiple mechanisms have been implied in
hypothermic neuroprotection in ischemia, but hypo-
glycemia is different from both ischemia and anoxia as it
is accompanied by an alkalization, rather than an acidifi-
cation. This alkalization removed the proton block of
NMDA receptors and allows their activation by aspartate
released from astrocytes. However, hypothermia decreases
the pH of aCSF such that our calculations, verified by
experimental measurement, show a 0.1 pH unit drop
from 7.4 to 7.3 when the temperature is decreased from
37°C to 27°C. This may have profound effects on the
involvement of NMDA receptors in the recovery phase
following aglycemia, since aglycemic injury is in part due
to aspartate activated NMDA receptors. Measurements of
aspartate during aglycemia show a delayed elevation
above baseline that persists for up to 20 min beyond
reperfusion of glucose containing aCSF (Yang et al.
2014). However, the aglycemia-induced alkalization atten-
uates rapidly post-aglycemia and the restoration of a rela-
tive acidic interstitial environment would block aspartate-
mediated activation of NMDA receptors. Introduction of
aCSF with pH of 7.55 would maintain an alkali environ-
ment during reperfusion that would allow continued
aspartate-induced activation of NMDA receptors and may
explain why there was little difference between CAP
recovery during global hypothermia and exposure to
hypothermia during reperfusion. Alternatively the sudden
acidification of the interstitial fluid resulting from
hypothermia may cause an increased gradient for lactate
uptake into axons via monocarboxylate transporter
uptake, which co-transports lactate with H+ (Halestrap
2012). The rapid restoration of the CAP after about
80 min in Figure 5A, supports a sudden influx of lactate
from the interstitial fluid that temporarily restores CAP
condition. However, once the lactate is exhausted it is not
replenished and the CAP fails.
Clinical implications
In comparing the effects of hypothermic neuroprotection
on GM and WM it is instructive to appreciate the differ-
ences in mechanism, with glutamate and aspartate medi-
ated activation of NMDA receptors occurring in GM, but
only aspartate contributing to WM. However, there are
additional nonglutamatergic mechanisms in place, namely
activation of VGCC and Na+-Ca2+exchanger. The
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alkalization that accompanies aglycemia relieved proton
block at the NMDA receptors in WM. However, this
effect can be attenuated by alkalizing the aCSF bathing
the tissue, which would ensure that the aspartate present
during the initial phases of reperfusion would persist in
its activation of NMDA receptors, an effect that would be
blocked by the rapid restoration of physiological pH on
cessation of aglycemia.
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